Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BIOCRYST PHARMACEUTICALS INC | 100,198 | reported | 28 Feb 2023 | tx 33+348,970 |
| Bausch Health Companies Inc. | 92,046 | reported | 31 Mar 2017 | tx 32+502,248−194,104 |
| WOLFSPEED, INC. | 77,710 | reported | 17 Oct 2018 | tx 57+107,210−11,500 |
| NORTEL NETWORKS CORP | 45,460.96 | reported | 31 Mar 2006 | tx 10+41,463.026 |
| Black Diamond Therapeutics, Inc. | 42,854 | reported | 16 Dec 2022 | tx 13+102,696 |
| LOWES COMPANIES INC | 32,429.88 | reported | 31 Mar 2011 | tx 43+58,060.632−32,000 |
| Edwards Lifesciences Corp | 32,367 | reported | 15 May 2015 | tx 34+53,503−75,412 |
| Novan, Inc. | 20,000 | reported | 28 Jul 2020 | tx 11+248,275−27,777 |
| ALLERGAN INC | 8,612.97 | reported | 29 Oct 2012 | tx 199+81,309.97−18,000 |
| REGENERON PHARMACEUTICALS, INC. | 1,500 | reported | 27 May 2015 | tx 6+37,505−11,834 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Feb 2023 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 2,259 | 8.85 USD | |
| 16 Dec 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 9,375 | 1.50 USD | |
| 30 Nov 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,497 | 13.36 USD | |
| 16 Sept 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 6,584 | 2.62 USD | |
| 31 Aug 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,438 | 13.90 USD | |
| 17 Jun 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 8,498 | 2.03 USD | |
| 10 Jun 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 07 Jun 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 12,866 | 0.00 USD | |
| 07 Jun 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 30,022 | 0.00 USD | deriv |
| 31 May 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 2,078 | 9.31 USD | |
| 18 Mar 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 5,795 | 3.02 USD | |
| 28 Feb 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,128 | 16.61 USD | |
| 17 Dec 2021 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 3,296 | 5.31 USD | |
| 30 Nov 2021 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,554 | 12.06 USD | |
| 17 Sept 2021 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 1,869 | 9.90 USD | |
| 31 Aug 2021 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,177 | 15.92 USD | |
| 18 Jun 2021 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 1,255 | 12.95 USD | |
| 18 Jun 2021 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 28 May 2021 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,188 | 15.77 USD | |
| 25 May 2021 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |
| 18 Mar 2021 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 677 | 24.01 USD | |
| 26 Feb 2021 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 1,739 | 10.78 USD | |
| 15 Dec 2020 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 505 | 34.29 USD | |
| 30 Nov 2020 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 3,669 | 5.11 USD | |
| 30 Sept 2020 | PURCHASE | Black Diamond Therapeutics, Inc. | 5,000 | 30.46 USD |
3 purchases reported after at least 12 months of silence — most recent on 28 Sept 2018.